Developer docs
API playgroundTry for free, no card

Search company profiles

Arbor Biosciences

Full company profile

uuid0009cq7

Namestring
Arbor Biosciences
Legal namestring
Biodiscovery LLC
Websiteurl
arborbiosci.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Arbor Biosciences (d/b/a Daicel Arbor Biosciences) is a development and manufacturing company founded in 2006 and headquartered in Ann Arbor, Michigan, specializing in genomics and synthetic biology research tools. It operates as a wholly owned subsidiary of Daicel Corporation, a Japanese diversified conglomerate, under the legal entity Biodiscovery LLC. The company serves academic, government, and commercial research customers across at least eight use-case verticals including agricultural genomics, biomedical and human health research, public health and microbiology, forensics, evolutionary biology and ecology, protein engineering, synthetic biology, and bacteriophage research. Arbor reports supporting thousands of research programs globally with an extensive peer-reviewed publications database.

Its product portfolio is built on proprietary flexible and customizable oligonucleotide pool synthesis technology and is organized around three core franchises: myBaits hybridization capture kits for targeted next-generation sequencing (NGS), myTags in situ hybridization probes for cytogenetics, and myTXTL cell-free protein expression kits for protein synthesis. These are complemented by a fourth franchise, myReads, which delivers laboratory and bioinformatics services covering long-read sequencing, DNA/RNA extraction, library preparation, targeted sequencing, and bioinformatics analysis. In-house manufacturing supports 3-4 week lead times for custom designs and 1-2 weeks for catalog or reorders, with product configurations available from 32 to 768 samples per kit.

The business model combines catalog sales of kits and consumables (priced per unit based on sample quantity, ranging from roughly $480 to $23,920 per kit) with quote-based custom configurations and project-based professional services. Go-to-market is hybrid: direct e-commerce for catalog purchases, scientific-expert-led direct sales for custom designs and enterprise engagements, and a global network of distribution partners for international reach. A co-marketing partnership with Element Biosciences extends reach into agricultural genomics via joint grant funding. The company maintains technical content marketing, peer-reviewed publication citation as social proof, webinar education, and conference participation (including PAG) as primary demand-generation channels.

Short descriptiontext

Arbor Biosciences is a Daicel-owned Ann Arbor-based developer and manufacturer of genomics and synthetic biology research tools — including myBaits targeted NGS kits, myTags ISH probes, myTXTL cell-free expression systems, and myReads lab/bioinformatics services — sold to academic, government, and biotech researchers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAnn Arbor, United States
HQ citystring
Ann Arbor
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
targeted NGS kits, hybridization capture, cell-free protein expression, in situ hybridization probes, genomics reagents
Industry5 codes
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Genomics Research Reagents
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1NGS Kits and Consumables
TypeOne Time License
Description

Sale of myBaits hybridization capture kits, library preparation kits, and related reagents for targeted next-generation sequencing applications. Products available in various sizes from 32 to 768 samples.

arborbiosci.com
2Cytogenetics Products
TypeOne Time License
Description

Sale of myTags in situ hybridization probes including custom and predesigned options for cytogenetics research applications.

arborbiosci.com
3Cell-Free Protein Expression Products
TypeOne Time License
Description

Sale of myTXTL cell-free protein expression kits including Pro Kit and Antibody/DS Kit options for protein synthesis applications.

arborbiosci.com
4Sequencing Services
TypeProfessional Services
Description

Comprehensive lab services including long-read sequencing, DNA/RNA extraction, library preparation, targeted sequencing, and NGS platform support through myReads service packages.

arborbiosci.com
5Bioinformatics Services
TypeProfessional Services
Description

Data analysis services including variant calling and alignment, and custom bioinformatics analyses for genomics projects.

arborbiosci.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details5 tiers
1Hyb reagents with library prep - bundled solution
ModelUnit PricingBilling cadencePay-as-you-go
Notes

32 samples: $1,125; 64 samples: $1,810; 128 samples: $3,235; 256 samples: $6,280; 768 samples: $18,220

arborbiosci.com
2Hyb reagents without library prep
ModelUnit PricingBilling cadencePay-as-you-go
Notes

32 samples: $480; 64 samples: $520; 128 samples: $890; 256 samples: $1,590; 768 samples: $4,150

arborbiosci.com
3Baits only - Bacteria/Virus/Protozoa panels
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Standard panels: 32 samples: $700-1,050; 64 samples: $1,260-1,890; 128 samples: $2,100-3,150; 256 samples: $3,150-4,730; 768 samples: $7,090-10,630 (varies by panel complexity)

arborbiosci.com
4Custom/made-to-order baits
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Custom microbial species baits: Express <1 Mbp to 10-15 Mbp genome sizes; 64-768 samples; prices range from $1,260 (64 samples, <1 Mbp) to $23,920 (768 samples, 10-15 Mbp)

arborbiosci.com
5Lab services - quote-based
ModelOtherBilling cadencePay-as-you-go
Notes

Sequencing and bioinformatics services priced per project based on requirements, complexity, and scale. Quote request required.

arborbiosci.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1myBaits
Description

Hybridization capture kits for targeted next-generation sequencing (NGS). Includes custom kits, predesigned kits, and specialized panels for various applications including microbial sequencing, UCE, mitochondrial DNA, and forensics.

arborbiosci.com
+3 more records
Core offering1 text field

Arbor Biosciences develops, manufactures, and sells proprietary genomics and proteomics research tools, including myBaits hybridization capture kits for targeted next-generation sequencing, myTags in situ hybridization probes for cytogenetics, and myTXTL cell-free protein expression kits. The company also provides laboratory services under the myReads brand, including long-read sequencing, DNA/RNA extraction, library preparation, targeted sequencing, and bioinformatics analyses, supporting researchers across agriculture, biomedical, public health, forensics, and synthetic biology applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Lower sequencing costs by reducing irrelevant data through targeted enrichment
+3 more records
Product overview1 text field

Daicel Arbor Biosciences offers a portfolio of specialized genomics and proteomics products organized into three main categories: Targeted NGS (myBaits hybridization capture kits and Library Prep kits for next-generation sequencing), Cytogenetics ISH (myTags in situ hybridization probes), and Cell-Free Protein Expression (myTXTL in vitro protein expression kits). The product portfolio also includes the myBaits Microbial Collection for pathogen sequencing and various predesigned expert panels. These products are complemented by laboratory services including sequencing (Long-Read, Extraction, Library Preparation, Targeted Sequencing) and bioinformatics services (Variant Calling, Custom Analyses) offered through the myReads service brand.

Product and service1 record
1myBaits Custom Hybridization Capture Kits
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Daicel Corporation
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Daicel Corporation is the parent company of Daicel Arbor Biosciences. The company operates as a subsidiary (d/b/a Daicel Arbor Biosciences) under the Daicel Group, a global specialty chemicals and performance products company.

arborbiosci.com
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Joint grant opportunity announced for accelerating agrigenomics research. The partnership combines Element Biosciences' AVITI sequencing platform capabilities with Daicel Arbor Biosciences' myBaits targeted sequencing solutions to support researchers in agricultural genomics.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Twist manufactures DNA synthesis products and custom NGS target enrichment panels that directly compete with Arbor's myBaits hybridization capture kits. Both companies serve genomics researchers with custom oligo pools and capture panels, making Twist the closest comparable in the core product line.

TypeDirect peer
Description

IDT's xGen Lockdown probes and NGS target enrichment reagents directly compete with myBaits. Both companies offer custom oligo pools for targeted sequencing and serve the same academic and agrigenomics customer base with overlapping applications.

TypeBroad incumbent
Description

Agilent's SureSelectXT hybridization capture kits are a major competitor in the targeted NGS space. As a much larger analytical instruments and life sciences company, Agilent competes across the same workflow stages as Arbor but with broader product breadth and stronger platform partnerships.

4Roche / NimbleGen (SeqCap)
TypeBroad incumbent
Description

Roche's NimbleGen SeqCap products are a legacy hybridization capture competitor in the targeted NGS market. As part of Roche's broader diagnostics and life sciences portfolio, SeqCap competes with myBaits particularly in clinical and translational research settings.

TypeBroad incumbent
Description

NEB supplies a wide range of molecular biology reagents, including NGS library prep and target enrichment tools that compete with Arbor's offerings. While NEB has a much broader enzyme and reagent catalog, it overlaps with Arbor in DNA sample prep and targeted sequencing workflows.

TypeBroad incumbent
Description

Qiagen offers sample preparation, NGS target enrichment, and bioinformatics solutions that overlap with Arbor's portfolio, particularly in microbial genomics and clinical research. As a much larger tools provider, Qiagen competes broadly across Arbor's application areas.

TypeDirect peer
Description

Zymo Research provides DNA/RNA extraction and microbial genomics solutions that overlap with Arbor's myReads extraction services and microbial sequencing panels. Both companies serve microbiome, infectious disease, and environmental research customers with integrated sample-to-analysis workflows.

TypeBroad incumbent
Description

Illumina dominates the NGS sequencing platform market on which Arbor's open-platform capture kits are deployed. While Illumina is upstream of Arbor in the workflow, its expanding menu of in-house enrichment and library prep products creates indirect competitive pressure on myBaits.

TypeOthers
Description

Eurofins Genomics offers sequencing and bioinformatics services that overlap with Arbor's myReads offerings. As a large international genomics services provider, Eurofins is a comparable service competitor for researchers outsourcing sample-to-data projects.

TypeDirect peer
Description

Sutro Biopharma operates one of the leading cell-free protein expression platforms (XpressCF) for therapeutic applications. While Sutro focuses on therapeutic-scale production and Arbor on research-scale myTXTL, both compete in the cell-free protein expression space identified as a USD 267M market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arbor Biosciences

Genomics Research Reagentsarborbiosci.com

Arbor Biosciences is a Daicel-owned Ann Arbor-based developer and manufacturer of genomics and synthetic biology research tools — including myBaits targeted NGS kits, myTags ISH probes, myTXTL cell-free expression systems, and myReads lab/bioinformatics services — sold to academic, government, and biotech researchers globally.

What Arbor Biosciences does

Arbor Biosciences (d/b/a Daicel Arbor Biosciences) is a development and manufacturing company founded in 2006 and headquartered in Ann Arbor, Michigan, specializing in genomics and synthetic biology research tools. It operates as a wholly owned subsidiary of Daicel Corporation, a Japanese diversified conglomerate, under the legal entity Biodiscovery LLC. The company serves academic, government, and commercial research customers across at least eight use-case verticals including agricultural genomics, biomedical and human health research, public health and microbiology, forensics, evolutionary biology and ecology, protein engineering, synthetic biology, and bacteriophage research. Arbor reports supporting thousands of research programs globally with an extensive peer-reviewed publications database.

Its product portfolio is built on proprietary flexible and customizable oligonucleotide pool synthesis technology and is organized around three core franchises: myBaits hybridization capture kits for targeted next-generation sequencing (NGS), myTags in situ hybridization probes for cytogenetics, and myTXTL cell-free protein expression kits for protein synthesis. These are complemented by a fourth franchise, myReads, which delivers laboratory and bioinformatics services covering long-read sequencing, DNA/RNA extraction, library preparation, targeted sequencing, and bioinformatics analysis. In-house manufacturing supports 3-4 week lead times for custom designs and 1-2 weeks for catalog or reorders, with product configurations available from 32 to 768 samples per kit.

The business model combines catalog sales of kits and consumables (priced per unit based on sample quantity, ranging from roughly $480 to $23,920 per kit) with quote-based custom configurations and project-based professional services. Go-to-market is hybrid: direct e-commerce for catalog purchases, scientific-expert-led direct sales for custom designs and enterprise engagements, and a global network of distribution partners for international reach. A co-marketing partnership with Element Biosciences extends reach into agricultural genomics via joint grant funding. The company maintains technical content marketing, peer-reviewed publication citation as social proof, webinar education, and conference participation (including PAG) as primary demand-generation channels.

Arbor Biosciences firmographics

Firmographics
Name
Arbor Biosciences
Legal name
Biodiscovery LLC
Website
https://arborbiosci.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Arbor Biosciences is a Daicel-owned Ann Arbor-based developer and manufacturer of genomics and synthetic biology research tools — including myBaits targeted NGS kits, myTags ISH probes, myTXTL cell-free expression systems, and myReads lab/bioinformatics services — sold to academic, government, and biotech researchers globally.
Ownership category
akta.pro rank

Arbor Biosciences industry classification

Industry
Product category
Genomics Research Reagents
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Targeted NGS kits
  • Hybridization capture
  • Cell-free protein expression
  • In situ hybridization probes
  • Genomics reagents

Where Arbor Biosciences is headquartered

Location

Headquarters

HQ city
Ann Arbor
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Arbor Biosciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. NGS Kits and Consumables: Sale of myBaits hybridization capture kits, library preparation kits, and related reagents for targeted next-generation sequencing applications. Products available in various sizes from 32 to 768 samples.
  2. Cytogenetics Products: Sale of myTags in situ hybridization probes including custom and predesigned options for cytogenetics research applications.
  3. Cell-Free Protein Expression Products: Sale of myTXTL cell-free protein expression kits including Pro Kit and Antibody/DS Kit options for protein synthesis applications.
  4. Sequencing Services: Comprehensive lab services including long-read sequencing, DNA/RNA extraction, library preparation, targeted sequencing, and NGS platform support through myReads service packages.
  5. Bioinformatics Services: Data analysis services including variant calling and alignment, and custom bioinformatics analyses for genomics projects.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goHyb reagents with library prep - bundled solution
Unit PricingPay-as-you-goHyb reagents without library prep
Unit PricingPay-as-you-goBaits only - Bacteria/Virus/Protozoa panels
One time/ perpetual licenseMulti-year contractCustom/made-to-order baits
OtherPay-as-you-goLab services - quote-based

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Arbor Biosciences product offering

Product offering

Core offering

Arbor Biosciences develops, manufactures, and sells proprietary genomics and proteomics research tools, including myBaits hybridization capture kits for targeted next-generation sequencing, myTags in situ hybridization probes for cytogenetics, and myTXTL cell-free protein expression kits. The company also provides laboratory services under the myReads brand, including long-read sequencing, DNA/RNA extraction, library preparation, targeted sequencing, and bioinformatics analyses, supporting researchers across agriculture, biomedical, public health, forensics, and synthetic biology applications.

Product overview

Daicel Arbor Biosciences offers a portfolio of specialized genomics and proteomics products organized into three main categories: Targeted NGS (myBaits hybridization capture kits and Library Prep kits for next-generation sequencing), Cytogenetics ISH (myTags in situ hybridization probes), and Cell-Free Protein Expression (myTXTL in vitro protein expression kits). The product portfolio also includes the myBaits Microbial Collection for pathogen sequencing and various predesigned expert panels. These products are complemented by laboratory services including sequencing (Long-Read, Extraction, Library Preparation, Targeted Sequencing) and bioinformatics services (Variant Calling, Custom Analyses) offered through the myReads service brand.

Differentiator

Problem solved

Functional benefit

Brands

  • myBaits: Hybridization capture kits for targeted next-generation sequencing (NGS). Includes custom kits, predesigned kits, and specialized panels for various applications including microbial sequencing, UCE, mitochondrial DNA, and forensics.
  • myTags
  • myTXTL
  • myReads

Products and services

  • myBaits Custom Hybridization Capture Kits

Quantifiable outcome

  • Lower sequencing costs by reducing irrelevant data through targeted enrichment
  • +3 more outcomes

Companies that use Arbor Biosciences

Customer profile

Segments8 records

Ideal customer profiles6 records

Arbor Biosciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Arbor Biosciences partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and strategic.

  • Daicel CorporationcoreOEM/ Whitelabel/ Licensing PartnerDaicel Corporation is the parent company of Daicel Arbor Biosciences. The company operates as a subsidiary (d/b/a Daicel Arbor Biosciences) under the Daicel Group, a global specialty chemicals and performance products company.
  • Element BiosciencesstrategicStrategic or Co-development PartnerJoint grant opportunity announced for accelerating agrigenomics research. The partnership combines Element Biosciences' AVITI sequencing platform capabilities with Daicel Arbor Biosciences' myBaits targeted sequencing solutions to support researchers in agricultural genomics.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Arbor Biosciences competitors and assessment

Company assessment

Direct peers

  • Twist Bioscience: Twist manufactures DNA synthesis products and custom NGS target enrichment panels that directly compete with Arbor's myBaits hybridization capture kits. Both companies serve genomics researchers with custom oligo pools and capture panels, making Twist the closest comparable in the core product line.
  • Integrated DNA Technologies (IDT): IDT's xGen Lockdown probes and NGS target enrichment reagents directly compete with myBaits. Both companies offer custom oligo pools for targeted sequencing and serve the same academic and agrigenomics customer base with overlapping applications.
  • Zymo Research: Zymo Research provides DNA/RNA extraction and microbial genomics solutions that overlap with Arbor's myReads extraction services and microbial sequencing panels. Both companies serve microbiome, infectious disease, and environmental research customers with integrated sample-to-analysis workflows.
  • Sutro Biopharma: Sutro Biopharma operates one of the leading cell-free protein expression platforms (XpressCF) for therapeutic applications. While Sutro focuses on therapeutic-scale production and Arbor on research-scale myTXTL, both compete in the cell-free protein expression space identified as a USD 267M market.

Broad incumbents

  • Agilent Technologies: Agilent's SureSelectXT hybridization capture kits are a major competitor in the targeted NGS space. As a much larger analytical instruments and life sciences company, Agilent competes across the same workflow stages as Arbor but with broader product breadth and stronger platform partnerships.
  • Roche / NimbleGen (SeqCap): Roche's NimbleGen SeqCap products are a legacy hybridization capture competitor in the targeted NGS market. As part of Roche's broader diagnostics and life sciences portfolio, SeqCap competes with myBaits particularly in clinical and translational research settings.
  • New England Biolabs (NEB): NEB supplies a wide range of molecular biology reagents, including NGS library prep and target enrichment tools that compete with Arbor's offerings. While NEB has a much broader enzyme and reagent catalog, it overlaps with Arbor in DNA sample prep and targeted sequencing workflows.
  • Qiagen: Qiagen offers sample preparation, NGS target enrichment, and bioinformatics solutions that overlap with Arbor's portfolio, particularly in microbial genomics and clinical research. As a much larger tools provider, Qiagen competes broadly across Arbor's application areas.
  • Illumina: Illumina dominates the NGS sequencing platform market on which Arbor's open-platform capture kits are deployed. While Illumina is upstream of Arbor in the workflow, its expanding menu of in-house enrichment and library prep products creates indirect competitive pressure on myBaits.

Others

  • Eurofins Genomics: Eurofins Genomics offers sequencing and bioinformatics services that overlap with Arbor's myReads offerings. As a large international genomics services provider, Eurofins is a comparable service competitor for researchers outsourcing sample-to-data projects.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Arbor Biosciences social profiles

Digital presence

Arbor Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arbor Biosciences leadership team

Management profile

Number of profiles

Profiles5 records

Arbor Biosciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arbor Biosciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arbor Biosciences

What does Arbor Biosciences do?

Arbor Biosciences develops, manufactures, and sells proprietary genomics and proteomics research tools, including myBaits hybridization capture kits for targeted next-generation sequencing, myTags in situ hybridization probes for cytogenetics, and myTXTL cell-free protein expression kits. The company also provides laboratory services under the myReads brand, including long-read sequencing, DNA/RNA extraction, library preparation, targeted sequencing, and bioinformatics analyses, supporting researchers across agriculture, biomedical, public health, forensics, and synthetic biology applications.

Is Arbor Biosciences a public or private company?

Arbor Biosciences is a private company. It is classified as corporate owned and is currently operating.

When was Arbor Biosciences founded?

Arbor Biosciences was founded in 2006. It employs 11 to 50 people.

Where is Arbor Biosciences based?

Arbor Biosciences is headquartered in Ann Arbor, United States, in the North America region.

How does Arbor Biosciences make money?

Five revenue lines are on record. NGS Kits and Consumables are the primary driver. The others are cytogenetics Products, cell-Free Protein Expression Products, sequencing Services and bioinformatics Services.

Who are Arbor Biosciences's main competitors?

Direct peers on record are Twist Bioscience, Integrated DNA Technologies (IDT), Zymo Research and Sutro Biopharma. Broad incumbents are Agilent Technologies, Roche / NimbleGen (SeqCap), New England Biolabs (NEB), Qiagen and Illumina. Eurofins Genomics is listed as an others.

Does Arbor Biosciences have an API?

No public API is recorded for Arbor Biosciences.

What industry is Arbor Biosciences in?

Arbor Biosciences's product category is Genomics Research Reagents. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGANAH, Microbiome & Metagenomics Services. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireSwift Biosciences And Arbor Biosciences Partner On Targeted NGS Workflows For CoronavirusSwift Biosciences and Arbor Biosciences announced a partnership to offer a complete workflow combining Swift's Adaptase®-powered RNA library preparation technology with Arbor's myBaits hybridization-based target enrichment technology for whole genome sequencing of SARS-CoV-2. The combined product offering includes modules for RNA fragmentation, reverse transcription, library preparation, indexed adapters, capture probes, and wash buffers for SARS-CoV-2 enrichment. The collaboration aims to support epidemiological research and public health surveillance by enabling labs to efficiently study viral mutation profiles even in heavily degraded samples or those with significant genomic rearrangements.SynBioBetaArbor Biosciences and LGC, Biosearch Technologies Partner on Marker Discovery and Genotyping in AgrigenomicsArbor Biosciences and LGC, Biosearch Technologies announced a partnership to provide custom sequencing solutions for the agrigenomics market. Under the agreement, Biosearch Technologies became the exclusive global provider of custom hybridization-based targeted sequencing oligonucleotide panels to commercial agricultural organizations and seed breeding companies. This collaboration combines Arbor's NGS target enrichment expertise with LGC's genotyping assays to serve key clients in the ag-bio sector.PR NewswireMedicinal Genomics, Arbor Biosciences Partner on Marker Discovery and Genotyping in CannabisMedicinal Genomics Corp. announced a partnership with Arbor Biosciences to introduce a new genotyping panel for cannabis that combines MGC's cannabis genome knowledge and genetic testing capabilities with Arbor's next-generation sequencing target enrichment technology. The jointly developed myBaits MGC Cannabis Panel will be co-branded and launched at the CannMed Conference in September 2019, incorporating the updated reference genome of the Jamaican Lion cultivar and markers for 30 cannabinoid and terpene synthase genes along with 20,000 SNPs for marker-assisted breeding. MGC will focus on serving recreational and medicinal cannabis breeders globally, while Arbor Biosciences will focus on the hemp market for textiles, foods, and building materials.